Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

512.12
Delayed Data
As of May 28
 -3.25 / -0.63%
Today’s Change
269.50
Today|||52-Week Range
519.46
+24.83%
Year-to-Date

Today’s Trading

Previous close515.37
Today’s open512.11
Day’s range-- - --
Volume702,544
Average volume (3 months)831,314
Market cap$53.2B
Dividend yield--
Data as of 05/28/2015

Growth & Valuation

Earnings growth (last year)-19.42%
Earnings growth (this year)+10.56%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+33.96%
P/E ratio164.1
Price/Sales14.64
Price/Book20.76

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-2.12-1.62%
QQuintiles Transnatio...+0.07+0.10%
ISISIsis Pharmaceuticals...-1.01-1.49%
ICLRICON PLC-0.04-0.06%
Data as of 05/28/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)$2.76
Annual revenue (last year)$2.8B
Annual profit (last year)$348.1M
Net profit margin12.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers